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Colon Cancer: Time for MRI has come?
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Introduction
Even if  the only currently curative treatment for colon 
cancer is surgery, recently there has been a growing 
discussion about the benefit of  neoadjuvant chemotherapy 
(nChT) for patients with locally advanced cancers at 
increased risk of  recurrence, upon recognition of  adverse 
prognostic factors. The first works about nChT in colon 
cancer have showed promising results.1-3 In specific, results 
from the FOXTROT trial, designed to evaluate the potential 
benefits of  nChT for patients with locally advanced colon 
cancer, are greatly expected.1 If  that treatment will become 
standard, pre-operative imaging will become a valuable tool 
to select patients for nChT.4
On the other hand, as some colon tumours are now surgically 
removed by laparoscopy, is important to recognize those 
patients in whom laparoscopy might not be appropriated, 
either because the tumor is bulky or locally advanced.5
Therefore, imaging could be important to select: 1) early 
cancers that may undergo surgical excision directly; 2) 
locally advanced cancers that may need nChT or require 
an open approach/radical surgery because of  involvement 
of  adjacent organs; and 3) metastatic cancers for which 
curative surgery is not primarily indicated.6 Traditionally, 
this selection has been performed by computed 
tomography (CT), but this method has some important 
limitations.7 As such, some recent works have focused on 
the role of  magnetic resonance imaging (MRI) in colon 
cancer staging.4,6,8-10
T Staging
For T staging, the primary endpoint should be the selection 
of  poor prognosis neoplasms (T3 tumours with >5 mm of  
extramural invasion – T3cd – and T4 tumours) as this was 
proven to possess a greater prognostic significance than the 
differentiation between T2 and T3 tumours,11 being also 
the entry criteria for the FOXTROT trial.1
Based on the available reports from the literature, detection 
of  T3cd/T4 tumours remains somewhat problematic with 
MRI. The low sensitivity reported by some authors4,6 
indicates that the lesions tend to be understaged possibly 
due to microscopic invasion of  the peri-colic fat, still 
impossible to depict with the currently available imaging 
modalities. Overstaging, mainly related to desmoplastic 
reaction surrounding the neoplasms, is also an important 
source of  false results. The apparent discrepancy between 
these and other studies which have yielded higher sensitivity 
values8-10 may be explained by several factors, including 
differences in patient selection, technical protocol and 
image interpretation.
Therefore, at the moment it seems clear that larger, 
multi-institutional studies as well as further technological 
development of  methods with higher spatial resolution and 
fewer artifacts, are still warranted in order to assess, in a 
more precise way, the true role of  MRI of  the colon as the 
imaging modality to better select patients for nChT if  this 
treatment becomes standard for colon cancer.
N Staging
Overall, results for nodal staging by MRI are relatively 
poor.4,6,8-10 It is known that lymph node diameter is not 
accurate for assessing nodal metastasis in colon cancer.12 
False negative results are thus related to microscopic 
metastatic deposits in normal-sized nodes, whereas false-
positives are caused by benign lymph nodes that are 
enlarged because of  inflammatory or reactive changes. As 
nodal staging by imaging is problematic, additional research 
is neede, in order to improve the detection of  nodal 
metastases in patients with colon cancer. If  the results 
coming from nodal characterization studies in patients 
with rectal cancer could be replicated in patients with colon 
cancer, then the use of  contrast media can increase the 
accuracy of  MRI, whereas DWI is probably not useful for 
nodal characterization.13-15
Estramural Venous Invasion
Extramural venous invasion (EMVI) can be recognized on 
MRI as direct invasion of  the tumor growing into or along 
a vascular structure, an irregular expansion of  peritumoral 
veins and/or irregular margins of  the vessel wall near the 
tumor site.16,17
Results available so far indicate sub-optimal ability of  MRI 
for detecting EMVI;4,6,8-10 in fact, similarly to what happens 
with lymph nodes, imaging has some problems in detecting 
microscopic metastasis and misdiagnosing inflammatory 
changes.
6Comparison with CT 
As there is not a definite role for nChT in colon cancer, 
imaging is not crucial for selecting patients for pre-
operative treatments. However, this may be changing in 
the future as the benefits of  nChT for patients with locally 
advanced colon cancer are currently under investigation.1 
If  imaging becomes fundamental for the selection of  
patients undergoing nChT, then modalities as accurate 
as possible are required. Distant and local staging of  
colon cancer is currently performed mainly with CT, 
which serves to determine local resectability, apart from 
detecting distant metastases. Nevertheless, a recent meta-
analysis demonstrated that CT has difficulties to detect 
tumor invasion beyond the bowel wall of  5 mm or more 
(T1–T3ab vs T3cd–T4) and nodal involvement; pooled 
sensitivities were 77% and 71%, respectively, whereas 
pooled specificities were 70% and 67%, respectively.7 
These numbers have raised a growing interest towards 
MRI for the assessment of  patients with colon cancer, as 
an alternative to CT.
Analyzing some of  the works that have compared MRI and 
CT, overall there seems to be a trend towards the ability to 
distinguish between locally advanced colon cancer defined 
as tumour stage T3cd-T4 from non-locally advanced cancers 
by either high resolution MRI or CT.6,9,10 However, high 
resolution MRI may possess an edge over CT, related to its 
high soft tissue discrimination that allows identification of  
prognostic factors, such as T-stage and extramural venous 
invasion. Nodal staging remains considerably imperfect 
by both imaging modalities. Moreover, MRI does not use 
ionizing radiation nor injection of  iodinated contrast media 
and furthermore imaging of  the colon can be combined 
with the imaging of  the liver. Since MRI is probably the 
best modality in the detection of  liver metastasis with a 
significantly higher sensitivity than CT,18 it may become 
a ‘one-stop-shop’ allowing evaluation of  the whole 
abdominal cavity.
Conclusions
The available literature suggests that MRI has the 
potential to become a valuable tool in primary staging 
of  colon cancer, essentially allowing identification of  
locally advanced disease  and additional risk factors, such 
as serosal involvement and EMVI. Nodal staging still 
needs improvement as characterization of  lymph nodes is 
unreliable.
Combined with its high sensitivity in detecting liver 
metastases, MRI can become a pivotal imaging modality 
for abdominal staging of  patients with colon cancer.
Furthermore, if  a paradigm shift in the diagnostic 
and therapeutic work-up of  colon cancer occurs, with 
introduction of  nChT for T3cd-T4 disease, MRI may play 
an important role in selecting patients who will benefit 
from that approach.
Ultimately, as the available research on this subject is still 
quite limited, more works are warranted in order to better 
determine the role of  MRI in colon cancer staging.
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